The steady growth of anxiety ...

The steady growth of anxiety disorders (isolated or in the structure of other diseases) requires mastering the skills of its treatment by general practitioners, who at a certain level of literacy would oversee the majority of patients with anxiety disorders. Strict rules of pathogenetic treatment in this case should be the following: selection of the best (mostly low) doses of drugs, careful consideration of all the contraindications, side effects and possible complications required a combination of pharmacotherapy and psychotherapy. Must be treated on an individual plan developed for each patient taking into account the form of the disease, the leading psychopathological symptom, disease dynamics, somatic condition. It is extremely important in treating patients with anxiety the creation and performance at all stages of treatment necessary psychotherapeutic situation and the implementation of social support for patients. Just as the surgeon can not operate in a "septic" conditions, and the psychiatrist is meaningless to treat the patient in psychotraumatic situation. Whatever the means nor assign patients, no matter what method of therapy or used to their best effect should be extremely friendly, sympathetic attitude toward the patient. For the treatment of anxiety disorders using drugs almost all classes of psychotropic drugs, mostly tranquilizers and increasingly anti-depressants. Application of the first allows for a quick but short anxiolytic effect, but at the same time fraught with the threat of dependence. Appointment of the second achieves a stable positive results in the treatment of anxiety without causing addiction, in this connection is preferable. Begin treatment of anxiety disorders is most justified antidepressants last generations, which include selective serotonin reuptake inhibitors (fluoxetine, Paxil, Zoloft, tsipramil), an activator of serotonin reuptake (coaxil) and selective noradrenergic and serotonergic antidepressant (remeron). They have the following distinct advantages: good tolerability (absence of behavioral toxicity), or the lack of slight severity of side effects, ease of use (once daily dose), the ability to safely combine with somatotropic drugs. In some cases, antidepressant monotherapy is ineffective, which requires inclusion in the scheme of neuroleptics, vegetotropnyh and nootropic drugs. Neuroleptic drugs of choice can be teralen, Eglon, sonapaks, fluanksol, risperidone. Finlepsin the drug with a broad spectrum of action, is effective against any of paroxysmal manifestations, including hot flashes, autonomic-vascular crises, migraine. Patient Education is an important part of any treatment plan. This process must instill in the patient's confidence, enforce their medical prescriptions and thereby improve the prognosis of the disease.